Glenmark Pharmaceuticals Ltd

About Glenmark Pharmaceuticals Ltd

Glenmark is a leading player in the discovery of new molecules, both NCEs (new chemical entity) and NBEs (new biological entity), with seven molecules in various stages of clinical development & pre-clinical development. The company has a significant presence in branded generics markets across emerging economies including India.

Sales Markets

Africa
Central America (e.g. Mexico)
East Asia (e.g. China, Japan, Korea)
Europe - EU countries
Europe - non EU (e.g. UK, Russia, ex-CIS countries)
Middle East Region (e.g. UAE)
North America (USA, Canada)
Oceania
South America (e.g. Brazil, Colombia)
South Asia (e.g. India, Pakistan, Sri Lanka)
South East Asia (e.g. Thailand, Philippines, Singapore)

IN
2015

On CPHI since

Compare

Add to favorites Added to favorites

Company types

Manufacturer/Innovator

Contact info

+91 22-40189759
Website
Glenmark House, B D Sawant Marg, Chakala, Off. Western Express Highway, Andheri East, 400099, Mumbai, Maharashtra, India

Glenmark Pharmaceuticals Ltd Resources (1)

News Robust sales growth at Indian pharma companies expected in current FY on pandemic recovery, says Fitch

Drug categories impacted by travel restrictions expected to see higher sales levels in FY22

14 Jun 2021

CPHI Online is the largest global marketplace in the pharma ingredients industry

Glenmark Pharmaceuticals Ltd

About Glenmark Pharmaceuticals Ltd

Sales Markets

Glenmark Pharmaceuticals Ltd Resources (1)

News Robust sales growth at Indian pharma companies expected in current FY on pandemic recovery, says Fitch

Position your company at the heart of the global Pharma industry with a CPHI Online membership

Coming soon

Glenmark Pharmaceuticals Ltd

Address

Telephone

Website

Request for general information